Personal information

Activities

Employment (1)

PHARMO Institute of Drug Outcomes Research: Utrecht, NL

2014-05-16 to present | Research Manager (Research)
Employment
Source: Self-asserted source
Elisabeth Smits

Works (7)

Sex differences in the intensity of statin prescriptions at initiation in a primary care setting

Heart
2024-08 | Journal article
Contributors: Pauline A J Kiss; Alicia Uijl; Annemarijn R de Boer; Tessa C X Duk; Diederick E Grobbee; Monika Hollander; Elisabeth Smits; Miriam C J M Sturkenboom; Sanne A E Peters
Source: check_circle
Crossref

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

BMJ Open
2024-03 | Journal article
Contributors: Gunnar Brobert; Ana Ruigomez; Tania Schink; Annemarie Voss; Ron Herings; Elisabeth Smits; Karin M A Swart; Leif Friberg; Yanina Balabanova; Christine Tarenz et al.
Source: check_circle
Crossref

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

PLOS ONE
2024-03-07 | Journal article
Contributors: Ana Ruigómez; Yoshihiro Fukumoto; Tania Schink; Annemarie Voss; Ron M. C. Herings; Elisabeth Smits; Karin Swart-Polinder; Yanina Balabanova; Gunnar Brobert; Kiliana Suzart-Woischnik et al.
Source: check_circle
Crossref

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

Drugs - Real World Outcomes
2023-06 | Journal article
Contributors: Annemarie Voss; Elisabeth Smits; Karin M. A. Swart; Yanina Balabanova; Gunnar Brobert; Kiliana Suzart-Woischnik; Ron M. C. Herings; Tania Schink; Ulrike Haug
Source: check_circle
Crossref

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

Expert Opinion on Drug Safety
2023-06-03 | Journal article
Contributors: Luis Alberto García Rodríguez; Ana Ruigómez; Tania Schink; Annemarie Voss; Elisabeth Smits; Karin M. A. Swart; Yanina Balabanova; Kiliana Suzart-Woischnik; Gunnar Brobert; Ron M. C. Herings
Source: check_circle
Crossref

Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany

Drugs - Real World Outcomes
2022-12 | Journal article
Contributors: Emily Holthuis; Elisabeth Smits; George Spentzouris; Dominik Beier; Dirk Enders; Rosa Gini; Claudia Bartolini; Giampiero Mazzaglia; Fernie Penning-van Beest; Ron Herings
Source: check_circle
Crossref

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany

Drugs - Real World Outcomes
2022-06 | Journal article
Contributors: Elisabeth Smits; Felicita Andreotti; Eline Houben; Harry J. G. M. Crijns; Sylvia Haas; George Spentzouris; Tania Schink; Rosa Gini; Claudia Bartolini; Fernie Penning-van Beest et al.
Source: check_circle
Crossref